Application
LMAN2 Antibody (C-term) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the LMAN2 antibody detected the LMAN2 protein (arrow).| Product Name | LMAN2 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | LMAN2; C5orf8; Vesicular integral-membrane protein VIP36; Glycoprotein GP36b; Lectin mannose-binding 2; Vesicular integral-membrane protein 36 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | C5orf8 |
|---|---|
| Alternative Names | LMAN2 C5orf8 Vesicular integral-membrane protein VIP36 Glycoprotein GP36b Lectin mannose-binding 2 Vesicular integral-membrane protein 36 |
| Molecular Weight(MW) | 40229 Da |
| Function | Plays a role as an intracellular lectin in the early secretory pathway. Interacts with N-acetyl-D-galactosamine and high-mannose type glycans and may also bind to O-linked glycans Involved in the transport and sorting of glycoproteins carrying high mannose-type glycans (By similarity) |
| Tissue Specificity | Ubiquitous. |
| Cellular Localization | Endoplasmic reticulum-Golgi intermediate compartment membrane; Single-pass type I membrane protein. Golgi apparatus membrane; Single-pass membrane protein. Endoplasmic reticulum membrane; Single-pass type I membrane protein |
| Entrez Gene | 10960 |
|---|---|
| Nucleotide Accession | NP_006807.1 |
Application
LMAN2 Antibody (C-term) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the LMAN2 antibody detected the LMAN2 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
